The increase in concentration of blood levels of FGF-23 (up to 3,400 mg/mL) was 50-fold in CKD-5D compared to CKD stage 2 levels, while the increase in bone osteocytes expressing FGF-23 was 18-fold. Here, FGF23 is linked to chronic kidney disease.